These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. Koo AN; Min KH; Lee HJ; Lee SU; Kim K; Kwon IC; Cho SH; Jeong SY; Lee SC Biomaterials; 2012 Feb; 33(5):1489-99. PubMed ID: 22130564 [TBL] [Abstract][Full Text] [Related]
43. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells. Wang X; Wang Y; Chen X; Wang J; Zhang X; Zhang Q J Control Release; 2009 Oct; 139(1):56-62. PubMed ID: 19470394 [TBL] [Abstract][Full Text] [Related]
44. Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model. Wu H; Xin Y; Zhao J; Sun D; Li W; Hu Y; Wang S Cancer Chemother Pharmacol; 2011 Oct; 68(4):879-87. PubMed ID: 21290245 [TBL] [Abstract][Full Text] [Related]
45. Preclinical evaluation of taxane-binding peptide-modified polymeric micelles loaded with docetaxel in an orthotopic breast cancer mouse model. Logie J; Ganesh AN; Aman AM; Al-Awar RS; Shoichet MS Biomaterials; 2017 Apr; 123():39-47. PubMed ID: 28161682 [TBL] [Abstract][Full Text] [Related]
46. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice. Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846 [TBL] [Abstract][Full Text] [Related]
47. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. Hwang HY; Kim IS; Kwon IC; Kim YH J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444 [TBL] [Abstract][Full Text] [Related]
48. Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin. Song W; Tang Z; Zhang D; Zhang Y; Yu H; Li M; Lv S; Sun H; Deng M; Chen X Biomaterials; 2014 Mar; 35(9):3005-14. PubMed ID: 24388813 [TBL] [Abstract][Full Text] [Related]
49. Improved anti-tumor efficiency against prostate cancer by docetaxel-loaded PEG-PCL micelles. Jin MJ; Piao SJ; Jin TX; Jin ZH; Yin XZ; Gao ZG J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):66-75. PubMed ID: 24496681 [TBL] [Abstract][Full Text] [Related]
50. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate. Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629 [TBL] [Abstract][Full Text] [Related]
51. Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer model. Li Y; Jin M; Shao S; Huang W; Yang F; Chen W; Zhang S; Xia G; Gao Z BMC Cancer; 2014 May; 14():329. PubMed ID: 24885518 [TBL] [Abstract][Full Text] [Related]
52. Anti-glioma effect and safety of docetaxel-loaded nanoemulsion. Gaoe H; Pang Z; Pan S; Cao S; Yang Z; Chen C; Jiang X Arch Pharm Res; 2012 Feb; 35(2):333-41. PubMed ID: 22370788 [TBL] [Abstract][Full Text] [Related]
53. Effects of organic solvents on drug incorporation into polymeric carriers and morphological analyses of drug-incorporated polymeric micelles. Harada Y; Yamamoto T; Sakai M; Saiki T; Kawano K; Maitani Y; Yokoyama M Int J Pharm; 2011 Feb; 404(1-2):271-80. PubMed ID: 21093556 [TBL] [Abstract][Full Text] [Related]
54. Preclinical pharmacologic evaluation of MST-997, an orally active taxane with superior in vitro and in vivo efficacy in paclitaxel- and docetaxel-resistant tumor models. Sampath D; Greenberger LM; Beyer C; Hari M; Liu H; Baxter M; Yang S; Rios C; Discafani C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3459-69. PubMed ID: 16740771 [TBL] [Abstract][Full Text] [Related]
55. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Kim TH; Mount CW; Gombotz WR; Pun SH Biomaterials; 2010 Oct; 31(28):7386-97. PubMed ID: 20598741 [TBL] [Abstract][Full Text] [Related]
56. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy. Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942 [TBL] [Abstract][Full Text] [Related]
57. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer. Verma P; Meher JG; Asthana S; Pawar VK; Chaurasia M; Chourasia MK Drug Deliv; 2016; 23(2):479-88. PubMed ID: 24901205 [TBL] [Abstract][Full Text] [Related]
58. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models. Wu Q; Deng S; Li L; Sun L; Yang X; Liu X; Liu L; Qian Z; Wei Y; Gong C Nanoscale; 2013 Dec; 5(24):12480-93. PubMed ID: 24165931 [TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier. Zhao X; Zhao Y; Geng L; Li X; Wang X; Liu Z; Wang D; Bi K; Chen X J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Dec; 879(31):3721-7. PubMed ID: 22035980 [TBL] [Abstract][Full Text] [Related]
60. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]